And if you stop taking it without solid habits in place, the research says you will regain most of the weight within two years
View The Five Stocks Here Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat
This would be the exception, not the rule
It is not yet approved for general medical use and remains in Phase 3 clinical trials, where researchers are assessing long-term safety, durability of weight loss, and broader metabolic benefits
PlexusDx ensures this relationship by requiring a complete medical history, current medication review, and contraindication screening before any prescription is issued
Nevertheless, the early findings suggest a beneficial trend worth considering in clinical practice